Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for September 22nd

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, September 22nd:

Genworth Financial, Inc. (GNW - Free Report) : This insurance solutions provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.8% over the last 60 days.

Genworth Financial has a price-to-earnings ratio (P/E) of 3.87, compared with 11.30 for the industry. The company possesses a Value Score of A.

Uniti Group Inc. (UNIT - Free Report) : This internally managed real estate investment trust has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.

Uniti Group has a price-to-earnings ratio (P/E) of 6.44, compared with 30.00 for the industry. The company possesses a Value Score of A.

SK Telecom Co., Ltd. (SKM - Free Report) : This wireless telecom services provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.6% over the last 60 days.

SK Telecom has a price-to-earnings ratio (P/E) of 7.86, compared with 10.60 for the industry. The company possesses a Value Score of A.

Ellington Residential Mortgage REIT (EARN - Free Report) : This real estate investment trust has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.

Ellington Residential Mortgage REIT has a price-to-earnings ratio (P/E) of 7.84, compared with 9.60 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>